300463.SZ SHZ
Maccura Biotechnology Co.Ltd
1W: +0.8%
1M: +3.0%
3M: +11.6%
YTD: -20.7%
1Y: -24.3%
3Y: -35.0%
5Y: -74.7%
¥9.53 ($1.42)
+0.20 (+2.14%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$634M
-29.7% ▼
5Y CAGR: +6.6%
Capital Expenditures
$963M
-9.7% ▼
5Y CAGR: +13.8%
Free Cash Flow
-$329M
-1494.7% ▼
Dividends Paid
$115M
+52.9% ▲
Buybacks
$25M
+0.0% ▲
Net Change in Cash
-$170M
-168.9% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $821M | $1.0B | $701M | $313M | $119M |
| Depreciation & Amort. | $205M | $236M | $270M | $318M | $337M |
| Stock-Based Comp. | $6M | $1M | $0 | $0 | $0 |
| Change in Working Capital | -$54M | $256M | -$244M | $174M | $24M |
| Other Non-Cash Items | $135M | $57M | $116M | $142M | $154M |
| Operating Cash Flow | $1.1B | $1.6B | $843M | $912M | $634M |
| — Investing Activities — | |||||
| Capital Expenditures | -$501M | -$602M | -$988M | -$878M | -$963M |
| Acquisitions (Net) | -$57M | -$67M | -$165M | $0 | $0 |
| Investment Purchases | -$5M | -$88M | -$2.4B | -$1.8B | -$580M |
| Investment Sales | $57M | $520K | $1.7B | $2.1B | $845M |
| Other Investing | $4M | $69M | $20M | $9M | $21M |
| Investing Cash Flow | -$503M | -$687M | -$1.8B | -$514M | -$677M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$183M | -$337M | -$309M | $95M | $73M |
| Stock Repurchased | -$6M | -$175M | $0 | $0 | -$25M |
| Dividends Paid | -$105M | -$238M | -$287M | -$245M | -$115M |
| Other Financing | -$138M | -$144M | $1.6B | -$3M | -$60M |
| Financing Cash Flow | -$433M | -$895M | $930M | -$153M | -$127M |
| Net Change in Cash | $153M | $33M | -$51M | $247M | -$170M |
| Cash End of Period | $583M | $616M | $564M | $811M | $641M |
| Free Cash Flow | $593M | $1.0B | -$145M | $24M | -$329M |